These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 23068712)

  • 1. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
    Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
    Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
    Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
    Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer.
    Mohamed S; Nielsen SK; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer.
    Liu H; Kinard J; Maurer J; Shang Q; Vanderstraeten C; Hayes L; Sintay B; Wiant D
    J Appl Clin Med Phys; 2018 Nov; 19(6):316-322. PubMed ID: 30284370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
    Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncertainty analysis for 3D image-based cervix cancer brachytherapy by repetitive MR imaging: assessment of DVH-variations between two HDR fractions within one applicator insertion and their clinical relevance.
    Lang S; Nesvacil N; Kirisits C; Georg P; Dimopoulos JC; Federico M; Pötter R
    Radiother Oncol; 2013 Apr; 107(1):26-31. PubMed ID: 23541645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of a new workflow for MRI/CT-based image-guided brachytherapy in cervical carcinoma.
    Nemoto MW; Iwai Y; Togasaki G; Kurokawa M; Harada R; Kobayashi H; Uno T
    Jpn J Radiol; 2017 Dec; 35(12):760-765. PubMed ID: 29039108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
    Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
    Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.
    Dincer N; Ugurluer G; Mustafayev TZ; Serkizyan A; Aydin G; Güngör G; Yapici B; Atalar B; Özyar E
    Brachytherapy; 2024; 23(1):18-24. PubMed ID: 38000958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
    Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
    Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
    Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
    Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring.
    Eskander RN; Scanderbeg D; Saenz CC; Brown M; Yashar C
    Int J Gynecol Cancer; 2010 Jan; 20(1):47-53. PubMed ID: 20130502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre comparison of the dosimetric impact of inter- and intra-fractional anatomical variations in fractionated cervix cancer brachytherapy.
    Nesvacil N; Tanderup K; Hellebust TP; De Leeuw A; Lang S; Mohamed S; Jamema SV; Anderson C; Pötter R; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):20-5. PubMed ID: 23602372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.